Robert A. Hetz

Suggest Changes
Learn More
BACKGROUND Autologous bone marrow-derived mononuclear cells (AMNCs) have shown therapeutic promise for central nervous system insults such as stroke and traumatic brain injury (TBI). We hypothesized(More)